Henry Ford Health and U.S. News & World Report’s Best Hospitals Survey

Henry Ford Health’s reputation for clinical excellence is built on the expertise and dedication of its physicians. People travel to Henry Ford Health from throughout the United States and across the world for our specialized, complex care.

Henry Ford Health is recognized for clinical excellence in cancer care, cardiology and cardiovascular surgery, neurology and neurosurgery, orthopedics, and sports medicine. Additionally, we handle some of the most complex organ transplant cases in the United States, including liver, kidney, pancreas, intestine and multivisceral organs, heart, lung and bone marrow stem cell.
Henry Ford Health is also a leading academic institution, committed to advancing tomorrow’s healthcare through clinical innovation, groundbreaking clinical trials, translational research, and training the next generation of healthcare professionals.

U.S. News & World Report Voting

Best Hospital rankings are determined in part by physician voting, and votes from those affiliated with Henry Ford Health - but not directly employed by Henry Ford Health - are considered “outside affiliations” with greater weight. By voting for Henry Ford Health hospitals, we can elevate our national reputation and all of us that are associated with the health system.

Who can vote?

Voting can be completed by board-certified physicians who have claimed their profile and practice in one of the 15 adult specialties ranked by U.S. News & World Report.

How do I vote?

All voting is done online through the Doximity platform. The voting window typically opens around mid-February and continues until mid-March.

Vote Now

How to claim your Doximity profile

1. Go to the app store and download Doximity for free.
2. Enter your First and Last Name.
3. Click “Find My Profile.”
4. Follow any additional prompts for information.
5. Enter email address and create a password.
6. Select “Complete Registration.”
7. Begin the verification process and complete and fields, as prompted.
8. Once verified, you will have full Doximity access.

Registered users will receive an email from Doximity with voting instructions. If an email is not received, those individuals may still vote by logging onto the Doximity site with their username and password and clicking on the U.S. News graphic on the home page.

Quality & Innovation Highlights at Henry Ford Health

Henry Ford Health specialists provide expert patient care that results in exceptional outcomes, even for the most complex cases.

Cancer

• The collection of the 6,000th tumor sample in the Henry Ford Hermelin Brain Tumor Center’s Brain Tumor Bank has taken place. The bank has grown into one of the largest and most respected tumor banks in the world – a resource that continues to power discoveries and transform how we understand, diagnose and treat brain tumors.
• Henry Ford Health is blazing the way in our region and the nation in the development and growth of Precision Medicine, a wide-ranging DNA-inspired approach to advance and enhance care in many specialties. Precision Medicine is the practice of using data, including, for example, each patient’s genes, environment and lifestyle factors to risk stratify and tailor the treatment.
• In a collaborative effort between Radiology, the Transplant Institute, Department of Urology, and Surgical Oncology/Cancer Center, Henry Ford can now offer patients a non-invasive treatment option for solid liver tumors. Spearheaded by Division Head of Transplant Surgery Atsushi Yoshida, MD; and Division Head of Interventional Radiology Nik Kolicaj, MD, this advanced technology was recently used to perform the first-ever Histotripsy procedure in the greater Detroit area, at Henry Ford Hospital.
• Our Complex Surgical Oncology team continues to evolve and lead the way to more targeted and successful outcomes, all while gaining national attention. Recently, the team launched its Hepatic Arterial Infusion (HAI) program – one of only two in Michigan. This effort has been spearheaded by the surgical team, including Rupen Shah, MD in partnership with Abbas Al-Kurd, MD from hepatobiliary surgery and Maria Diab, MD from medical oncology. This program offers an option for patients with liver-dominant advanced cancers that otherwise do not have meaningful treatment options.
• Dr. Rupen Shah was recently selected as Vice Chair of the peritoneal surface malignancy disease site working group of the Society of Surgical Oncology (SSO). This prestigious role places Dr. Shah and Henry Ford Health at the forefront of national conversations shaping best practices in advanced surgical cancer therapies.
• The Henry Ford Advanced Therapeutic Endoscopy group, in collaboration with Surgical Oncology, has recently incorporated endoscopic ultrasound (EUS)–guided, needle-based confocal laser endomicroscopy (nCLE) into its standard clinical workflow for the evaluation of pancreatic cystic lesions. This advanced imaging technology is offered by only a few centers nationwide. This group is also participating in an ongoing national multicenter clinical trial (CLIMB study), which seeks to further evaluate the accuracy and safety of this technology and to advance diagnostic strategies for pancreatic cystic lesions nationwide.
• In 2025, the team at Henry Ford St. John Hospital performed Michigan’s first ever pressurized intraperitoneal aerosolized chemotherapy (PIPAC). The procedure is a highly specialized and innovative minimally invasive laparoscopic treatment for patients with advanced colorectal, appendiceal, gastric, ovarian, and other cancers. These patients may not benefit from traditional IV chemotherapy or HIPEC.
• Henry Ford Macomb Hospital made history in 2025 with a world-first usage of an AI-powered navigation system during an operation to remove lung nodules in a patient. They used the MONARCH robotic bronchoscopy platform with MONARCH™ QUEST, which uses AI to assist with navigation, allowing for improved precision in targeting lung nodules.
• Cardiac thoracic surgeon Raed Alnajjar, MD performed a Single-Port (SP) robotic lung cancer resection, the first procedure of its kind in Michigan and one of only a handful performed throughout the country. Unlike the traditional multi-port Da Vinci robotic system, the SP platform requires only a single small incision, which translates into less pain, faster recovery, and minimal scarring for patients. The system offers enhanced precision, improved control, and a magnified 3D view – features that enable us to perform complex thoracic procedures with greater dexterity and reduced tissue trauma.
• The Henry Ford Pancreatic Cancer Center – one of only a few in the US – was recently designated as a National Center of Excellence by the National Pancreas Foundation. The HFPCC anchors a unique global consortium of academic, industry, and international partners, which continues to accelerate the capacity to change the trajectory of this disease.

Heart & Vascular

• Our Sarcoidosis Lung Disease Program was officially designated as a World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) Center of Excellence. This designation is held by only 34 other centers in the U.S., and it is the first of its kind in Michigan.
• Henry Ford Innovations uses 3D-printed heart models to transform cardiac care, providing three-dimensional precision beyond standard imaging. These models surpass CT scans by simulating valve placement and selection, ensuring precise fit in complex cases and reducing leakage risks like heart failure.
• • The cardiovascular team at Henry Ford Rochester Hospital completed an implant of a first-of-its-kind extravascular defibrillator on a 37-year-old patient who had sustained VT and cardiac arrest. The Aurora EV-ICD™ system treats sudden cardiac arrest and abnormal heart rhythms with defibrillation and antitachycardia pacing (ATP) in a single device. It is the only ICD placed outside the vascular space that provides ATP in a single device and is nearly half the size with 60% greater projected battery longevity than the subcutaneous implantable cardioverter defibrillator (S-ICD).
• In November 2025, the cardiovascular team at Henry Ford Macomb Hospital performed the health system’s first robotic mitral valve repair surgery. The robotic procedure is done via five small incisions and provides the patient with a shorter hospital stay, faster recovery, less pain, lower chance of complications, and improved cosmetics. This procedure is available at only a small percentage of hospitals in the country, putting Henry Ford Health in an elite group of health systems to offer this option.
• A patient at Henry Ford Hospital received one of the first BrioVADs in the country. This implant is possible at only seven chosen centers across the U.S., as part of the Innovate Trial. This new pump is intended to support patients with end stage heart failure or recalcitrant cardiogenic shock, allowing discharge to home and survival that is up to 500 times better than that of medical management alone.

Neurology & Neurosurgery

• Research Scientist Mohammad Ejaz Ahmed, PhD, was recently awarded a prestigious R01 grant totaling $2.2 million from the NIH to explore the metabolic regulation of Neutrophil Extracellular Traps (NETs) in traumatic brain injury (TBI). This project will investigate how activation of the energy-sensing enzyme AMPK influences NET formation and inflammation in the brain following TBI. By understanding the interplay between metabolism and immune response, the research aims to uncover new therapeutic strategies to reduce inflammation and improve outcomes for patients suffering from TBI.
• Our adoption of RapidAI, a platform that can accelerate stroke diagnosis and treatment, recently earned us a spotlight in the AMA news. This is an augmented intelligence (AI) tool that analyzes CT scans for large vessel occlusion and instantly sends images and notifications to clinicians’ mobile devices. This technology allows our team to respond immediately and with the appropriate level of care.
• Zehra Farzal, MD and Judy (Yikun) Wang, DO were the first in Michigan to use the adaptive Deep Brain Stimulation (aDBS) technology. This delivers constant stimulation to help control brain stimulation resulting in involuntary movement such as in Parkinson’s Disease, essential tremors (ET) or cervical dystonia.
• Together with the Neuro ICU team, Henry Ford Innovations invented a 3D-printed clip to secure the connection between extra ventricular drains (EVD) and transducers, helping to prevent infection from environmental exposure. The clip has worked flawlessly for more than six years. In that time, there has not been a single connection issue between an EVD and transducer.
• Neurosurgeon Adam Robin, MD and radiation oncologist M. Salim Siddiqui, MD, PhD, teamed up to perform a first-in-the-world procedure to implant Cs-131 radiation seeds (Gamma Tile) into the spine of a patient with recurrent and progressive colorectal cancer. With the support of Henry Ford Innovations, the team 3D-printed the patient’s anatomy to model the procedure and radiation plans. The success of this innovative approach has the potential to pave the way for future advancements in the treatment of spinal metastases. It highlights the essential roles that both neurosurgery and radiation oncology play in developing comprehensive, patient-centered therapies.
• Tisa Johnson-Hooper, MD is spearheading our GROW Center for Autism and Intellectual/Developmental Disabilities. The center is a multidisciplinary program, which combines pediatric care across specialties, diagnostics, therapies and research for pediatric patients with autism or another intellectual disability.
• We recently performed the first two stentoplasties using a first-of-its-kind FDA-approved device (Neva DS). This procedure treated recalcitrant cerebral vasospasm, which was complicating an aneurysmal subarachnoid hemorrhage.
• The Henry Ford Movement Disorders Center at Henry Ford Hospital has been nationally recognized as an HDSA Center of Excellence. With this recognition, the team at Henry Ford Hospital will receive a financial award to channel into its care and services for those they serve in the community with Huntington’s Disease.
• Neurologist Alex Bou Chebl, MD recently performed the first two stentoplasties using a first-of-its-kind FDA-approved device (Neva DS). This procedure treated recalcitrant cerebral vasospasm, which was complicating an aneurysmal subarachnoid hemorrhage.

Otolaryngology

• Henry Ford Hospital has been recognized as a Best Hospital for 2024-25 in the Ear, Nose & Throat specialty by U.S. News & World Report, which features the top 50 of America’s “Best Hospitals” in 15 specialties.
• In 2022, the Skull Base team at Henry Ford Hospital in Detroit earned a Multidisciplinary Team of Distinction designation from the North American Skull Base Society (NASBS), which recognizes NASBS member institutions that have skull base surgery teams comprising physicians in a variety of specialties and disciplines. Henry Ford’s Skull Base team was one of only two in Michigan, and one of only 38 total, to receive the Team of Distinction.
• Researchers from Henry Ford Health + Michigan State University Health Sciences have been awarded a $3 million grant from the National Institute of Dental and Craniofacial Research to study new treatments for patients who have head and neck cancer caused by the human papillomavirus, or HPV.
• Henry Ford Health is in the top 10th percentile for time of initiation of postoperative radiation therapy for head and neck cancer patients (< 6 weeks).

Transplant

• As Michigan’s most comprehensive transplant program, Henry Ford Transplant offers transplantation of the liver, kidney, pancreas, intestine and multivisceral organs, heart, lung and bone marrow stem cell. The Institute is always on the forefront of transplantation science and performs the most advanced minimally invasive procedures and living organ donations for liver and kidney transplants. Our commitment to quality leads to outcomes that meet or exceed expected survival rates where we use the most effective clinical strategies to increase transplant rates while maintaining superior patient outcomes.
• Kyle Miletic, MD, performed our state’s second beating heart transplant in 2024. Since that time, he and his team have performed four more. Among many benefits, a beating heart transplant allows the team to receive donor hearts from greater distances.

Quality & Safety

• The American College of Surgeons (ACS) selected Henry Ford Hospital for Achieving Meritorious Outcomes for Surgical Patient Care. Hospital surgical outcomes were categorized in two ways – All Cases Meritorious and High-Risk Meritorious. Henry Ford Hospital was among only 39 hospitals recognized in both categories and was the only hospital in Michigan to make this prestigious list, which was selected as part of the ACS National Surgical Quality Improvement Program (NSQIP).
• Four Henry Ford Health hospitals (Henry Ford Hospital in Detroit, Henry Ford Jackson Hospital, Henry Ford Providence Novi Hospital, and Henry Ford West Bloomfield Hospital) received ‘A’ ratings for safety by the Leapfrog Group – the most for any hospital system in the state.
• Henry Ford Health earned national distinction with the American Medical Association’s Joy in Medicine® Award, honoring healthcare organizations that prioritize proven methods to reduce burnout and enhance the professional fulfillment of doctors that comes from patient care.
• We were named the American Medical Group Association’s 2025 Acclaim Award recipient. The Acclaim Award honors healthcare delivery organizations that are bringing the American healthcare system closer to the ideal delivery model – one that is safe, effective, patient-centered, timely, efficient, and equitable.
• In a historic first for Henry Ford Health, Henry Ford Hospital in Detroit has earned Level IV Maternal Center certification from The Joint Commission, in collaboration with the American College of Obstetricians and Gynecologists (ACOG) — the top designation for hospitals caring for high-risk pregnancies. The Level IV certification is the most advanced classification offered through the Joint Commission’s Maternal Levels of Care (MLC) Verification program. It signifies that Henry Ford Hospital is equipped to provide comprehensive care for the most complex maternal cases — from critically ill pregnant individuals to those with significant co-morbid conditions or fetal complications.
• Henry Ford Hospital in Detroit, Henry Ford Jackson Hospital, and Henry Ford West Bloomfield Hospital have achieved Magnet® designation, awarded by the American Nurses Credentialing Center (ANCC). This recognition represents the highest level of professionalism in nursing practice and is the gold standard in nursing excellence

Urology

• Vattikuti Urology Institute is the leading and most experienced prostate cancer program in the world. As the pioneers of robotic prostatectomy, Vattikuti Urology Institute’s innovations have made robotic prostatectomy the surgical standard of care for prostate cancer. Patients seeking the best care have traveled to Detroit from all 50 states and every continent -- including Antarctica -- to receive treatment from the urologists at Henry Ford. With our innovative, multidisciplinary approach, we are also the training center for surgeons around the globe in robotic prostate surgery, kidney and adrenal surgery, bladder surgery and pediatric urologic procedures.
• We are home to a highly motivated, multidisciplinary research team dedicated to advancing excellence in urological care. Our work spans the full spectrum of health outcomes research, including racial and socioeconomic disparities in care, challenges faced by vulnerable populations such as incarcerated patients, and the impact of neighborhood poverty on health outcomes. We lead numerous initiatives evaluating the quality of urological care delivered at Henry Ford Health and across the nation, develop advanced AI-driven models to predict cancer control outcomes, and conduct randomized clinical trials testing innovative, next-generation surgical approaches, including precision prostatectomy. Over the years, our team has generated multiple practice-changing studies that have been incorporated into national and international clinical guidelines. With more than 60 peer-reviewed publications annually, our research enterprise ranks among the top 5% in academic productivity nationwide.
• In 2023, Henry Ford Health was the first health system in Michigan to offer ExactVu, a cutting-edge technology for diagnosing and evaluating prostate cancer. Enhancing the precision and speed of diagnosis, this new technology ensures patients receive timely and appropriate care, while also providing a more efficient and convenient experience than other diagnostic methods.
• In 2021, surgeons at Henry Ford Health System’s Vattikuti Urology Institute (VUI) performed the world's first precision prostatectomy through the bladder using a single port robotic surgical system.
• Nabeel Shakir, MD is one of 12 recipients of the American Urological Association/Urology Care Foundation Research Scholar Awards to support his unique collaboration between the Center for Health Policy & Health Services Research, the Department of Urology and the Division of Interventional Radiology at Henry Ford Health. Dr. Shakir will lead the academic portion of the grant for his project, “A Multiphase Optimization Strategy to Reduce Delays in Management of Chronic Nephrostomy Tubes.”
• Our urology team at Henry Ford West Bloomfield Hospital recently completed its first Aquablation therapy procedure, expanding access to an innovative, minimally invasive treatment option to men with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland. This milestone makes West Bloomfield the first Henry Ford Health location - and one of only a few in Michigan - to offer Aquablation therapy.